U.S. spending $5 billion to speed up development of new COVID vaccines
On Apr. 10, 2023, the U.S. Department of Health and Human Services (HHS) announced it was spending over…
-
-
Pfizer RSV vaccine 82% effective vs severe infection in infants, final data showed
On Apr. 5, 2023, Pfizer announced that experimental respiratory syncytial virus (RSV) vaccine was 82% effective in preventing…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | NIH | Therapeutics | Vaccine
Frequent testing reduced COVID-19 deaths in nursing facilities
On Apr. 4, 2023, National Institutes of Health (NIH) funded research was announced from the University of Rochester…
-
Moderna finalized agreement with Government of the Republic of Kenya to establish an mRNA manufacturing facility
On Mar. 30, 2023, Moderna and the Government of the Republic of Kenya announced they had finalized an…
-
Biotechnology | CDC | COVID-19 | Diagnostics | Vaccine
Tuberculosis in the U.S. increased slightly during 2022 although it remained lower than prepandemic years
On Mar. 24, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced that Tuberculosis (TB) in…
-
Biotechnology | COVID-19 | NIH | Pharmaceutical | Vaccine
SARS-CoV-2 infection weakens immune-cell response to vaccination
On Mar. 20, 2023, NIH scientists announced that the magnitude and quality of a key immune cellﾒs response…
-
Vaccine makers prep bird flu shot for humans ‘just in case’; rich nations lock in supplies
On Mar. 20, 2023, some of the world’s leading makers of flu vaccines said they could make hundreds…
-
Biotechnology | Diagnostics | Infectious Disease | Polio | Vaccine | WHO
Circulating vaccine-derived poliovirus type 2 (cVDPV2) reported in Indonesia
On Mar. 17, 2023, the Indonesia Ministry of Health notified the World Health Organization (WHO) of the detection…
-
FDA authorized bivalent Pfizer-BioNTech COVID-19 vaccine as booster dose for certain children 6 months through 4 years of age
On Mar. 14, 2023, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) of the…
-
Advisory Committee on Immunization Practices recommended universal Hepatitis B vaccination in adults aged 19-59 years
On Mar. 10, 2023, the Centers for Disease Control and Prevention (CDC) recommended the universal hepatitis B (HepB)…
-
Biotechnology | FDA | Measles | Vaccine
U.S. FDA approved intramuscular administration for Merck’s MMRV Vaccines: M-M-RII, VARIVAX, and ProQuad
On Mar. 6, 2023, Merck announced that the U.S. Food and Drug Administration had approved the addition of…
-
Pfizer and BioNTech submitted for U.S. EUA of Omicron BA.4/BA.5-adapted bivalent COVID-19 booster in children under 5 years
On Mar. 1, 2023, BioNTech and Pfizer announced that they had submitted an application to the U.S. Food…
-
Biotechnology | Diagnostics | Infectious Disease | Influenza | Neurology | NIH | Prehistory | Vaccine
Influenza viruses may have originated in fish 600 million years ago
On Feb. 28, 2023, a team from the University of Sydney reported that a flu virus found in…
-
Avian Influenza A (H5N1) reported in Cambodia
On Feb. 26, 2023, the Cambodia International Health Regulations (IHR) National Focal Point (NFP) reported one confirmed case…
-
Moderna to make milestone payments to NIH for COVID vaccine
On Feb. 24, 2023, Moderna announced will make certain contingent development, commercial and regulatory milestone payments to the…
-
FDA authorized first OTC at-home test to detect both influenza and COVID-19 viruses
On Feb. 24, 2023, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for…
-
Flu vaccine provided substantial protection during 2022-23 season
On Feb. 22, 2023, the Centers for Disease Control and Prevention (CDC) reported that the 2022-2023 flu vaccines…
-
Health Canada authorized Moderna’s Omicron-targeting bivalent COVID-19 vaccine in children & Adolescents
On Feb. 17, 2023, Moderna announced that Health Canada had authorized the use of its Omicron-targeting bivalent COVID-19…
-
Lancet study published on natural immunity protection by COVID variant
On Feb. 16, 2023, it was reported in the Lancet that protection from past infection against re-infection from…
-
Moderna to provide free COVID-19 vaccines after U.S. public health emergency ends
On Feb. 15, 2023, Moderna announced it will continue to offer its COVID-19 vaccines for free, even after…
-
CPRIT approved $12 million to bring top-flight cancer researchers to Lone Star State
On Feb. 15, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced a major step forward…
-
NIH scientists develop mouse model to study Mpox virulence
On Feb. 14, 2023, scientists from the National Institute of Allergy and Infectious Diseases announced they had developed…
-
U.S. Government and Novavax extend partnership for 1.5 million additional doses of Novavax’ COVID-19 vaccine
On Feb. 13, 2023, Novavax announced a modification to its existing agreement with the U.S. Department of Health…
-
Bird flu has begun to spread in mammals
On Feb. 8, 2023, as bird flu continues to circle the globe, a new report suggested that the…
-
Biotechnology | COVID-19 | Diagnostics | FDA | Infectious Disease | Influenza | Vaccine
BD received FDA EUA for COVID-19, influenza A/B, RSV combination test
On Feb. 8, 2023, BD announced that it had received Emergency Use Authorization from the U.S. Food and…
-
Bivalent boosters provided better protection against severe COVID-19
On Feb. 7, 2023, an NIH funded study by University of North Carolina reported that Bivalent booster vaccines…
-
Biotechnology | Disease | NIH | Therapeutics | Vaccine
Experimental NIH Sudan virus vaccine protected Macaques
On Feb. 2, 2023, a National Institutes of Health research group with extensive experience studying ebolavirus countermeasures successfully…
-
U.S. household spread of flu more than doubled during the 2021-2022 season compared to pre-COVID-19 pandemic levels
On Jan. 26, 2023, Centers for Disease Control and Prevention (CDC) reported that U.S. household spread of flu…
-
OHSU researchers found immune response to COVID-19 strengthens over time
On Jan. 25, 2023, researchers at Oregon Health & Science University (OHSU) reported that Immunity from COVID-19 appears…
-
Novavax Nuvaxovid COVID-19 vaccine approved in South Korea as an adult booster
On Jan. 18, 2023, Novavax announced that partner SK bioscience had received expanded manufacturing and marketing approval from…
